Skip to Main Content

MyAANS, password-protected resources, and purchases are currently experiencing issues and are unavailable. We are working to get this fixed as soon as possible.

AANS and CNS Support the Safe Step Act

On March 16, the AANS and the CNS joined the Alliance of Specialty Medicine in supporting the Safe Step Act (S. 464/H.R. 2163), sponsored by Sens. Lisa A. Murkowski (R-Alaska), Margaret Wood Hassan (D-N.H.), Bill Cassidy, MD, (R-La.) and Jacky Rosen (D-Nev.) in the Senate, and Reps. Raul Ruiz, MD, (D-Calif.), Brad Wenstrup, DPM, (R-Ohio), Lucy McBath (D-Ga.) and Mariannette Miller-Meeks, MD, (R-Iowa) in the House. Health insurers often use step therapy — also called “fail first” — to control costs. Step therapy occurs when insurers require patients to fail the first step of treatment — typically a generic or low-cost drug — before moving on to the second step. This legislation would require health plans to establish specific exceptions to medication step-therapy protocols.

Click here to read the Alliance of Specialty Medicine letter.